Cozart acquires drugs-of-abuse testing co Medib
This article was originally published in Clinica
Executive Summary
Abingdon, UK-based Cozart has paid SKr5.3m ($0.7m) to acquire Medib Skandinavien, a supplier of point-of-care urine tests for drugs of abuse in Sweden and Denmark. The Hollviken, Sweden company reported revenues of SKr5.3m and pre-tax profits of SKr1.1m in the year ended April 30 2005.